About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.

The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes.

Related: Crazy-expensive weight loss drugs may soon see a major change In other news, The Biden Administration is set to introduce a change that could impact more than 7 million people covered by Medicare and Medicaid.

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

GLP-1 medications like Ozempic and Wegovy are shielding the kidneys from harm, even as they help ease diabetes and obesity. Folks taking the meds have significantly lower odds for

A new study published in The Lancet Diabetes & Endocrinology found that GLP-1 drugs can also protect your kidneys from damage. This is the largest study which analysed the effects of the drugs on the kidneys of people with or without diabetes.